Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 857-874
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.857
Table 1 Characteristic baseline of patients in sets
Variables
Total set (n = 190)
Training set (n = 106)
Internal test set (n = 47)
External test set (n = 37)
P value
VETC (%)0.986
Positive94 (49)53 (50)23 (49)18 (49)
Negative96 (51)53 (50)24 (51)19 (51)
Age (median, IQR)57 (51, 66)58.5 (51, 65.75)56 (51.5, 67.5)57 (50, 64)0.708
Sex (%)0.555
Male153 (81)83 (78)38 (81)32 (86)
Female37 (19)23 (22)9 (19)5 (14)
Hepatitis (%)0.799
HBV or/and HCV171 (90)96 (91)41 (87)34 (92)
Negative19 (10)10 (9)6 (13)3 (8)
Cirrhosis (%)0.008
Present158 (83)85 (80)36 (77)37 (100)
Absent32 (17)21 (20)11 (23)0 (0)
ALT (median, IQR)32 (19, 51.75)28 (18, 49)40 (22.5, 63)33 (22, 45)0.094
AST (median, IQR)37 (25, 61.5)36.5 (23.25, 1.75)49 (28.5, 78)30 (24, 46)0.041
GGT (median, IQR)59.25 (31, 131.25)61.75 (30, 127)76 (38.5, 143.5)49 (27, 98)0.157
AFP (median, IQR)49.06 (5.54, 9.25)62.74 (6.62, 9.25)56.78 (5.87, 16.5)34.74 (5.22, 798)0.516
Main tumor size (median, IQR)5.7 (3.2, 9.28)6.05 (3.02, 9.3)6.9 (3.45, 11.15)4.11 (3.2, 6.5)0.098
Multiplicity (%)0.037
≥ 246 (24)29 (27)14 (30)3 (8)
1144 (76)77 (73)33 (70)34 (92)
Single lobe involvement (%)0.064
Present141 (74)74 (70)34 (72)33 (89)
Absent49 (26)32 (30)13 (28)4 (11)
Intratumor hemorrhage (%)0.179
Present12 (6)9 (8)3 (6)0 (0)
Absent178 (94)97 (92)44 (94)37 (100)
Intratumor necrosis (%)0.131
Present95 (50)57 (54)25 (53)13 (35)
Absent95 (50)49 (46)22 (47)24 (65)
Arterial phase hyper enhancement (%)0.701
Present179 (94)101 (95)44 (94)34 (92)
Absent11 (6)5 (5)3 (6)3 (8)
Well defined capsule (%)0.143
Present140 (74)75 (71)33 (70)32 (86)
Absent50 (26)31 (29)14 (30)5 (14)
Washout (%)0.249
Present187 (98)105 (99)45 (96)37 (100)
Absent3 (2)1 (1)2 (4)0 (0)
Non-smooth tumor margin (%)0.435
Present116 (61)69 (65)26 (55)21 (57)
Absent74 (39)37 (35)21 (45)16 (43)